Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia

NCT00384930 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

1058

Enrollment

INDUSTRY

Sponsor class

Conditions

Benign Prostatic Hyperplasia

Interventions

DRUG: tadalafil
DRUG: tadalafil
DRUG: tadalafil
DRUG: tadalafil
DRUG: placebo

Sponsor

Eli Lilly and Company

Collaborators

[object Object]